TCL Archive AACR To Hold Separate Annual Meeting, Seeks ‘More Meaningful’ Interaction With Clinicians May 29, 1992
TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013